By Counterforce Health Team in Kymriah (tisagenlecleucel) —

How to Get Kymriah (tisagenlecleucel) Covered by Humana in Michigan: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Kymriah (tisagenlecleucel) Approved by Humana in Michigan

Kymriah (tisagenlecleucel) requires prior authorization from Humana Medicare Advantage, with coverage limited to FDA-approved indications like relapsed/refractory B-cell precursor ALL or large B-cell lymphoma after specific prior therapies. Michigan patients have strong appeal rights: if denied, you have 65 days to file a redetermination with Humana, then 127 days to request external review through Michigan's Department of Insurance and Financial Services (DIFS). For urgent cases, expedited appeals are decided within 72 hours (Humana) or 72 hours (DIFS external review).

First step today: Have your oncologist submit Humana's CAR-T prior authorization form with detailed medical necessity documentation, including prior therapy failures and FDA indication confirmation.

Table of Contents

Why Michigan State Rules Matter for Kymriah Coverage

Michigan's Patient's Right to Independent Review Act (PRIRA) provides crucial protections for patients seeking coverage of high-cost specialty drugs like Kymriah. Unlike many states, Michigan gives you 127 days (approximately four months) to file an external review after a final denial—longer than the federal 120-day standard.

For Humana Medicare Advantage members, this creates a dual-layer protection system. First, you work through Humana's internal processes following CMS guidelines. If that fails, Michigan's independent review process provides a second chance with binding decisions from medical experts.

Note: Michigan's protections apply to commercial plans and some Medicare Advantage denials, but ERISA self-funded employer plans may have different rules.

Humana's Prior Authorization Requirements

Coverage at a Glance

Requirement What It Means Source
Prior Authorization Required Yes, for all CAR-T therapies including Kymriah Humana CAR-T Policy
FDA Indication Required Must meet labeled uses (B-cell ALL ≤25 years, DLBCL/FL adults) Humana Medical Policy
Certified Treatment Center Must be administered at approved CAR-T facility CMS Coverage Guidelines
Prior Therapy Documentation Evidence of failed conventional treatments required Humana PA Form
Decision Timeline 30 days standard, 72 hours expedited Medicare SOC

Key Coverage Criteria

Humana follows CMS guidelines requiring:

  • Confirmed CD19+ disease with appropriate histology
  • Failed prior therapies per FDA labeling (typically 2+ lines for adults)
  • Treatment at certified center with CAR-T capabilities
  • Conditioning regimen plan documented
  • REMS program enrollment confirmed

Step-by-Step: Fastest Path to Approval

1. Verify Insurance Benefits

Who: Patient or clinic staff
Action: Call Humana member services to confirm CAR-T coverage and PA requirements
Timeline: Same day

2. Gather Required Documentation

Who: Oncology team
Documents needed:

  • Pathology confirming CD19+ disease
  • Complete treatment history with dates, drugs, responses
  • Current staging and disease status
  • Laboratory values (CBC, metabolic panel, organ function)

3. Submit Prior Authorization

Who: Prescribing physician
Action: Complete Humana's CAR-T Medicare Advantage form
Submit via: Humana provider portal or fax (verify current number)
Timeline: Allow 5-7 business days for review

4. Request Expedited Review if Urgent

Who: Physician
Criteria: Disease progression risk or clinical deterioration
Timeline: 72-hour decision

5. Monitor Decision

Who: Patient and clinic
Action: Track via Humana member portal
Next steps: If approved, coordinate with CAR-T center; if denied, proceed to appeals

Michigan Appeal Timelines and Standards

Internal Appeals with Humana

Appeal Level Filing Deadline Decision Timeline How to File
Redetermination 65 days from denial 7 calendar days Humana Appeals Portal
Expedited Internal Within 65 days 72 hours Phone + written follow-up

Michigan External Review Process

After exhausting Humana's internal appeals, Michigan patients can request independent review through DIFS:

Standard External Review:

Expedited External Review:

  • Filing deadline: 10 days from adverse determination
  • Decision timeline: 72 hours
  • Requirements: Physician letter stating delay would seriously jeopardize health

External Review Through DIFS

Michigan's Department of Insurance and Financial Services provides robust external review protections for CAR-T therapy denials.

When You're Eligible

  • Completed Humana's internal appeal process
  • Denial involves medical necessity determination
  • Treatment is covered benefit under your plan
  • Request filed within 127 days

Required Documentation

Submit to DIFS:

  • Final denial letter from Humana
  • All medical records supporting Kymriah necessity
  • Physician letter detailing urgency (for expedited review)
  • Completed DIFS external review request form

The Review Process

  1. Assignment: DIFS assigns case to Independent Review Organization (IRO)
  2. Medical Review: IRO's clinical experts evaluate medical necessity
  3. Decision: Binding determination issued within timeline
  4. Implementation: If overturned, Humana must approve coverage immediately

Contact DIFS: Call 877-999-6442 for assistance with the external review process.

Common Denial Reasons and How to Overturn Them

Denial Reason How to Overturn Key Documentation
"Not FDA-approved indication" Confirm diagnosis matches label Pathology report, ICD-10 codes
"Insufficient prior therapy" Document all failed treatments Treatment timeline, toxicity records
"Not at certified center" Transfer to approved CAR-T facility Center certification verification
"Experimental/investigational" Cite FDA approval and CMS coverage FDA label, CMS guidelines
"Not medically necessary" Strengthen clinical justification Guidelines, peer review studies
From our advocates: We've seen Humana denials overturned when oncologists clearly documented why conventional chemotherapy failed and included specific toxicity details. The key is painting a complete picture of treatment history, not just listing drug names.

Clinician Corner: Medical Necessity Documentation

Essential Elements for Kymriah PA Letters

Patient History:

  • Confirmed CD19+ B-cell malignancy with pathology
  • Complete prior treatment regimen details (drugs, dates, cycles, responses)
  • Documented treatment failures, toxicities, or contraindications
  • Current performance status and organ function

Clinical Rationale:

  • Why Kymriah is appropriate for this specific patient
  • Reference to FDA prescribing information
  • Alignment with professional society guidelines (NCCN, ASH)
  • Treatment goals and expected outcomes

Supporting Evidence:

  • Recent imaging and laboratory studies
  • Multidisciplinary team recommendations
  • CAR-T center evaluation and acceptance
  • REMS program enrollment plan

Peer-to-Peer Review Strategy

If initial PA is denied, request peer-to-peer review with Humana's medical director:

  • Prepare 10-15 minute presentation
  • Focus on patient-specific factors
  • Emphasize time-sensitive nature of CAR-T therapy
  • Reference Humana's own coverage policy criteria

When to Escalate to State Regulators

Contact Michigan DIFS if you experience:

  • Procedural violations: Missed deadlines, improper notice
  • Access barriers: Unreasonable PA requirements
  • Pattern issues: Multiple inappropriate denials

Michigan DIFS Contact:

Include in your complaint:

  • Timeline of events
  • All correspondence with Humana
  • Medical documentation
  • Specific Michigan insurance law violations

Cost Assistance and Patient Support

Manufacturer Support

Novartis Oncology Patient Assistance: Financial assistance for eligible patients

  • Income-based support available
  • Covers copays, coinsurance, and deductibles
  • Contact: 1-800-282-7630

Foundation Resources

  • Leukemia & Lymphoma Society: Copay assistance program
  • CancerCare: Financial assistance and case management
  • Patient Access Network Foundation: Disease-specific grants

Michigan-Specific Programs

  • Michigan Department of Health and Human Services: Medicaid coverage for eligible patients
  • University of Michigan Rogel Cancer Center: Financial counseling services

Counterforce Health helps patients, clinicians, and specialty pharmacies navigate complex prior authorization and appeals processes. Their platform can assist with generating evidence-backed appeals that align with payer-specific requirements, potentially improving approval rates for high-cost therapies like Kymriah.

FAQ: Michigan Kymriah Coverage

How long does Humana prior authorization take for Kymriah in Michigan? Standard PA decisions take up to 30 days, but expedited reviews are completed within 72 hours when urgency is documented by your physician.

What if Kymriah isn't on Humana's formulary? Submit a formulary exception request within 72 hours using Humana's coverage determination form, including prescriber justification for medical necessity.

Can I appeal a Humana denial in Michigan? Yes. You have 65 days to file a redetermination with Humana, then 127 days to request external review through Michigan DIFS if the internal appeal fails.

Does step therapy apply to Kymriah? Humana typically requires documentation of failed conventional therapies before approving CAR-T, but this aligns with FDA labeling rather than arbitrary step therapy protocols.

What if I need Kymriah urgently? Request expedited review at both the PA and appeals stages. Your oncologist must document why delay would seriously jeopardize your health or ability to regain maximum function.

Are there continuity protections if I change insurance? Michigan Medicaid has continuity of care protections effective February 2026. For commercial plans, contact Counterforce Health for assistance navigating coverage transitions during ongoing CAR-T therapy.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions are made by your health plan based on your specific policy terms and medical circumstances. Always consult with your healthcare provider and insurance plan directly for coverage determinations. For personalized assistance with prior authorization and appeals, contact your healthcare team or organizations like Counterforce Health that specialize in insurance advocacy.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.